April 19, 2022
Via: The Wall Street JournalJohnson & Johnson JNJ +3.04% suspended full-year guidance for sales of its Covid-19 vaccine, citing a global surplus of doses and uncertainty over how the course of the pandemic will affect demand. The healthcare-products company said Tuesday that Covid-19 shots […]
February 29, 2024
March 7, 2024